Cargando…
Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression
Early detection is critical in prevention and treatment of kidney disease. However currently clinical laboratory and histopathological tests do not provide region-specific and accurate biomarkers for early detection of kidney disease. The present study was conducted to identify sensitive biomarkers...
Autores principales: | Chen, Hua, Cao, Gang, Chen, Dan-Qian, Wang, Ming, Vaziri, Nosratola D., Zhang, Zhi-Hao, Mao, Jia-Rong, Bai, Xu, Zhao, Ying-Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066525/ https://www.ncbi.nlm.nih.gov/pubmed/27750081 http://dx.doi.org/10.1016/j.redox.2016.09.014 |
Ejemplares similares
-
Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease
por: Chen, Dan-Qian, et al.
Publicado: (2017) -
Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis
por: Zhang, Zhi-Hao, et al.
Publicado: (2015) -
Microbiome–metabolome reveals the contribution of gut–kidney axis on kidney disease
por: Chen, Yuan-Yuan, et al.
Publicado: (2019) -
Metabolomics analysis reveals the association between lipid abnormalities and oxidative stress, inflammation, fibrosis, and Nrf2 dysfunction in aristolochic acid-induced nephropathy
por: Zhao, Ying-Yong, et al.
Publicado: (2015) -
Protective Effect of Nrf2 and Catalase in Maternal Diabetes-Induced Perinatal Hypertension and Kidney Disease
por: Vaziri, Nosratola D.
Publicado: (2012)